Biocryst Pharmaceuticals (BCRX) EBITDA Margin (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted EBITDA Margin of 45.35% for Q2 2026, up 26.92 percentage points from 18.44% a year earlier and up 493.23 percentage points from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) EBITDA Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Biocryst Pharmaceuticals was -33.05%, down 43.00 percentage points year-over-year; for FY2025, it came in at 39.14%, up 39.42 percentage points from FY2024.
- Annual EBITDA Margin has increased for five consecutive years, with a five-year change of +1016.06 percentage points (FY2020 to FY2025).
- In prior years, Biocryst Pharmaceuticals' EBITDA Margin was -0.29% in FY2024 (+30.51 pp), -30.79% in FY2023 (+23.48 pp), -54.28% in FY2022 (+58.30 pp) and -112.58% in FY2021 (+864.34 pp).
- Quarterly EBITDA Margin has run from a low of -447.88% in Q1 2026 to a high of 64.14% in Q4 2025 over five years.
- On a year-over-year basis, EBITDA Margin increased in seven of the last eight quarters, with an average year-over-year change of -31.77 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2021, with a gain of 1190.14 percentage points; the weakest was Q1 2026, with a drop of 462.69 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -447.88% (Q1 2026), 64.14% (Q4 2025) and 18.77% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Biocryst Pharmaceuticals | 2.16 Bn | 1.08 Bn | 214.41 Mn | 45.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.35% |
| Mar 31, 2026 | -447.88% |
| Dec 31, 2025 | 64.14% |
| Sep 30, 2025 | 18.77% |
| Jun 30, 2025 | 18.44% |
| Mar 31, 2025 | 14.81% |
| Dec 31, 2024 | -3.19% |
| Sep 30, 2024 | 6.84% |
| Jun 30, 2024 | 8.31% |
| Mar 31, 2024 | -15.29% |
| Dec 31, 2023 | -45.23% |
| Sep 30, 2023 | -13.26% |
| Jun 30, 2023 | -24.60% |
| Mar 31, 2023 | -40.73% |
| Dec 31, 2022 | -57.72% |
| Sep 30, 2022 | -22.49% |
| Jun 30, 2022 | -52.47% |
| Mar 31, 2022 | -99.43% |
| Dec 31, 2021 | -110.28% |
| Sep 30, 2021 | -108.20% |
API Access
Biocryst Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();